Eli Lilly to buy Centessa for $6.3B to get sleep disorder drugnews2026-03-31T11:04:34+00:00March 31st, 2026|Endpoints News|
#ACC26: Merck touts comparator data for oral cholesterol drugnews2026-03-30T18:33:20+00:00March 30th, 2026|Endpoints News|
Drugmakers skeptical of new White House overtures on pricingnews2026-03-30T17:58:06+00:00March 30th, 2026|Endpoints News|
#ACC26: Merck leans toward lower Winrevair dose in Phase 3 trial for rare form of heart failurenews2026-03-29T16:00:49+00:00March 29th, 2026|Endpoints News|
Otsuka buys Transcend Therapeutics for $700M upfrontnews2026-03-27T18:21:02+00:00March 27th, 2026|Endpoints News|
CHMP recommends subcutaneous form of Sanofi’s Sarclisa and four new drugsnews2026-03-27T17:29:48+00:00March 27th, 2026|Endpoints News|
FDA approves Novo Nordisk’s once-weekly insulinnews2026-03-27T13:43:46+00:00March 27th, 2026|Endpoints News|
Post-Hoc: It’s time to make ACIP serious againnews2026-03-26T14:04:48+00:00March 26th, 2026|Endpoints News|
More changes ahead for Takeda with new CEO set to take reinsnews2026-03-25T18:59:59+00:00March 25th, 2026|Endpoints News|
How Seaport is hedging against failure in Phase 2b depression studynews2026-03-25T18:00:28+00:00March 25th, 2026|Endpoints News|
